Maternal circulating concentrations of soluble Fas and Elabela in early- and late-onset preeclampsia

References

• ACOG Practice Bulletin No. 202: gestational hypertension and preeclampsia. Obstet Gynecol. 2019;133(1):e1–e25.
   PubMed Web of Science ®Google Scholar
• von Dadelszen P, Magee LA, Roberts JM. Subclassification of preeclampsia. Hypertens Preg. 2003;22(2):143–148.
   PubMed Web of Science ®Google Scholar
• Tranquilli AL, Brown MA, Zeeman GG, et al. The definition of severe and early-onset preeclampsia. Statements from the International Society for the Study of Hypertension in Pregnancy (ISSHP). Preg Hypertens. 2013;3(1):44–47.
   Web of Science ®Google Scholar
• Redman CW, Sargent IL, Staff AC. IFPA Senior Award Lecture: making sense of pre-eclampsia – two placental causes of preeclampsia? Placenta. 2014;35(Suppl.):S20–S25.
   PubMed Web of Science ®Google Scholar
• Duley L. The global impact of pre-eclampsia and eclampsia. Semin Perinatol. 2009;33(3):130–137.
   PubMed Web of Science ®Google Scholar
• Romero R, Lockwood C, Oyarzun E, et al. Toxemia: new concepts in an old disease. Semin Perinatol. 1988;12(4):302–323.
   PubMed Web of Science ®Google Scholar
• Paruk F, Moodley J. Maternal and neonatal outcome in early- and late-onset pre-eclampsia. Semin Neonatol. 2000;5(3):197–207.
   PubMedGoogle Scholar
• MacKay AP, Berg CJ, Atrash HK. Pregnancy-related mortality from preeclampsia and eclampsia. Obstet Gynecol. 2001;97(4):533–538.
   PubMed Web of Science ®Google Scholar
• Smith GC, Pell JP, Walsh D. Pregnancy complications and maternal risk of ischaemic heart disease: a retrospective cohort study of 129,290 births. Lancet. 2001;357(9273):2002–2006.
   PubMed Web of Science ®Google Scholar
• von Dadelszen P, Menzies J, Magee LA. The complications of hypertension in pregnancy. Minerva Med. 2005;96(4):287–302.
   PubMedGoogle Scholar
• Khan KS, Wojdyla D, Say L, et al. WHO analysis of causes of maternal death: a systematic review. Lancet. 2006;367(9516):1066–1074.
   PubMed Web of Science ®Google Scholar
• Bellamy L, Casas JP, Hingorani AD, et al. Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis. BMJ. 2007;335(7627):974.
   PubMed Web of Science ®Google Scholar
• Sibai BM. Hypertensive disorders of pregnancy: the United States perspective. Curr Opin Obstet Gynecol. 2008;20(2):102–106.
   PubMed Web of Science ®Google Scholar
• Berg CJ, Mackay AP, Qin C, et al. Overview of maternal morbidity during hospitalization for labor and delivery in the United States: 1993–1997 and 2001–2005. Obstet Gynecol. 2009;113(5):1075–1081.
   PubMed Web of Science ®Google Scholar
• Kuklina EV, Ayala C, Callaghan WM. Hypertensive disorders and severe obstetric morbidity in the United States. Obstet Gynecol. 2009;113(6):1299–1306.
   PubMed Web of Science ®Google Scholar
• Hutcheon JA, Lisonkova S, Joseph KS. Epidemiology of pre-eclampsia and the other hypertensive disorders of pregnancy. Best Pract Res Clin Obstet Gynaecol. 2011;25(4):391–403.
   PubMed Web of Science ®Google Scholar
• Adams T, Yeh C, Bennett-Kunzier N, et al. Long-term maternal morbidity and mortality associated with ischemic placental disease. Semin Perinatol. 2014;38(3):146–150.
   PubMed Web of Science ®Google Scholar
• Lisonkova S, Sabr Y, Mayer C, et al. Maternal morbidity associated with early-onset and late-onset preeclampsia. Obstet Gynecol. 2014;124(4):771–781.
   PubMed Web of Science ®Google Scholar
• Kilpatrick SJ, Abreo A, Greene N, et al. Severe maternal morbidity in a large cohort of women with acute severe intrapartum hypertension. Am J Obstet Gynecol. 2016;215(1):91.e1–91.e7.
   Web of Science ®Google Scholar
• Ozimek JA, Eddins RM, Greene N, et al. Opportunities for improvement in care among women with severe maternal morbidity. Am J Obstet Gynecol. 2016;215(4):509.e1–509.e6.
   Web of Science ®Google Scholar
• Tooher J, Thornton C, Makris A, et al. Hypertension in pregnancy and long-term cardiovascular mortality: a retrospective cohort study. Am J Obstet Gynecol. 2016;214(6):722.e1–722.e6.
   Web of Science ®Google Scholar
• Fields JA, Garovic VD, Mielke MM, et al. Preeclampsia and cognitive impairment later in life. Am J Obstet Gynecol. 2017;217(1):74–74.e11.
   PubMed Web of Science ®Google Scholar
• Madazli R, Yuksel MA, Imamoglu M, et al. Comparison of clinical and perinatal outcomes in early- and late-onset preeclampsia. Arch Gynecol Obstet. 2014;290(1):53–57.
   PubMed Web of Science ®Google Scholar
• Palatnik A, Grobman WA, Miller ES. Is a history of preeclampsia associated with an increased risk of a small for gestational age infant in a future pregnancy? Am J Obstet Gynecol. 2016;215(3):355.e1–355.e6.
   Web of Science ®Google Scholar
• Perger L, Mukhopadhyay D, Komidar L, et al. Maternal pre-eclampsia as a risk factor for necrotizing enterocolitis. J Matern Fetal Neonatal Med. 2016;29(13):2098–2103.
   PubMed Web of Science ®Google Scholar
• Sharma KJ, Esakoff TF, Guillet A, et al. Pregnancies complicated by both preeclampsia and growth restriction between 34 and 37 weeks’ gestation are associated with adverse perinatal outcomes. J Matern Fetal Neonatal Med. 2017;30(19):2342–2345.
   PubMed Web of Science ®Google Scholar
• van Esch JJA, van Heijst AF, de Haan AFJ, et al. Early-onset preeclampsia is associated with perinatal mortality and severe neonatal morbidity. J Matern Fetal Neonatal Med. 2017;30(23):2789–2794.
   PubMed Web of Science ®Google Scholar
• Hammad IA, Meeks H, Fraser A, et al. Risks of cause-specific mortality in offspring of pregnancies complicated by hypertensive disease of pregnancy. Am J Obstet Gynecol. 2020;222(1):75.e1–75.e9.
   Web of Science ®Google Scholar
• Marins LR, Anizelli LB, Romanowski MD, et al. How does preeclampsia affect neonates? Highlights in the disease’s immunity. J Matern Fetal Neonatal Med. 2019;32(7):1205–1212.
   PubMed Web of Science ®Google Scholar
• Pelicia SMdC, Fekete SMW, Corrente JE, et al. The effect of early-onset preeclampsia on the intestinal blood flow of preterm infants. J Matern Fetal Neonatal Med. 2019;1–5. DOI:https://doi.org/10.1080/14767058.2019.1661378
   Google Scholar
• Zwertbroek EF, Franssen MTM, Broekhuijsen K, et al. Neonatal developmental and behavioral outcomes of immediate delivery versus expectant monitoring in mild hypertensive disorders of pregnancy: 2-year outcomes of the HYPITAT-II trial. Am J Obstet Gynecol. 2019;221(2):154–154.e11.
   PubMed Web of Science ®Google Scholar
• Kestenbaum B, Seliger SL, Easterling TR, et al. Cardiovascular and thromboembolic events following hypertensive pregnancy. Am J Kidney Dis. 2003;42(5):982–989.
   PubMed Web of Science ®Google Scholar
• McDonald SD, Malinowski A, Zhou Q, et al. Cardiovascular sequelae of preeclampsia/eclampsia: a systematic review and meta-analyses. Am Heart J. 2008;156(5):918–930.
   PubMed Web of Science ®Google Scholar
• Lykke JA, Langhoff-Roos J, Sibai BM, et al. Hypertensive pregnancy disorders and subsequent cardiovascular morbidity and type 2 diabetes mellitus in the mother. Hypertension. 2009;53(6):944–951.
   PubMed Web of Science ®Google Scholar
• Garovic VD, Bailey KR, Boerwinkle E, et al. Hypertension in pregnancy as a risk factor for cardiovascular disease later in life. J Hypertens. 2010;28(4):826–833.
   PubMed Web of Science ®Google Scholar
• Brown MC, Best KE, Pearce MS, et al. Cardiovascular disease risk in women with pre-eclampsia: systematic review and meta-analysis. Eur J Epidemiol. 2013;28(1):1–19.
   PubMed Web of Science ®Google Scholar
• Wu P, Haththotuwa R, Kwok CS, et al. Preeclampsia and future cardiovascular health: a systematic review and meta-analysis. Circ Cardiovasc Qual Outcomes. 2017;10(2): pii: e003497.
   PubMed Web of Science ®Google Scholar
• Wikström AK, Haglund B, Olovsson M, et al. The risk of maternal ischaemic heart disease after gestational hypertensive disease. BJOG. 2005;112(11):1486–1491.
   PubMed Web of Science ®Google Scholar
• Lykke JA, Langhoff-Roos J, Lockwood CJ, et al. Mortality of mothers from cardiovascular and non-cardiovascular causes following pregnancy complications in first delivery. Paediatr Perinat Epidemiol. 2010;24(4):323–330.
   PubMed Web of Science ®Google Scholar
• Mannisto T, Mendola P, Vaarasmaki M, et al. Elevated blood pressure in pregnancy and subsequent chronic disease risk. Circulation. 2013;127(6):681–690.
   PubMed Web of Science ®Google Scholar
• Auger N, Fraser WD, Schnitzer M, et al. Recurrent pre-eclampsia and subsequent cardiovascular risk. Heart. 2017;103(3):235–243.
   PubMed Web of Science ®Google Scholar
• Robertson WB, Brosens I, Dixon G. Maternal uterine vascular lesions in the hypertensive complications of pregnancy. Perspect Nephrol Hypertens. 1976;5:115–127.
   PubMedGoogle Scholar
• Roberts JM, Taylor RN, Musci TJ, et al. Preeclampsia: an endothelial cell disorder. Am J Obstet Gynecol. 1989;161(5):1200–1204.
   PubMed Web of Science ®Google Scholar
• Pijnenborg R, Anthony J, Davey DA, et al. Placental bed spiral arteries in the hypertensive disorders of pregnancy. BJOG. 1991;98(7):648–655.
   Web of Science ®Google Scholar
• Roberts JM, Taylor RN, Goldfien A. Clinical and biochemical evidence of endothelial cell dysfunction in the pregnancy syndrome preeclampsia. Am J Hypertens. 1991;4(8):700–708.
   PubMed Web of Science ®Google Scholar
• Salafia CM, Pezzullo JC, López-Zeno JA, et al. Placental pathologic features of preterm preeclampsia. Am J Obstet Gynecol. 1995;173(4):1097–1105.
   PubMed Web of Science ®Google Scholar
• Dekker GA, van Geijn HP. Endothelial dysfunction in preeclampsia. Part I: primary prevention. Therapeutic perspectives. J Perinat Med. 1996;24(2):99–117.
   PubMed Web of Science ®Google Scholar
• Redman CW, Sacks GP, Sargent IL. Preeclampsia: an excessive maternal inflammatory response to pregnancy. Am J Obstet Gynecol. 1999;180(2):499–506.
   PubMed Web of Science ®Google Scholar
• Aardema MW, Oosterhof H, Timmer A, et al. Uterine artery Doppler flow and uteroplacental vascular pathology in normal pregnancies and pregnancies complicated by pre-eclampsia and small for gestational age fetuses. Placenta. 2001;22(5):405–411.
   PubMed Web of Science ®Google Scholar
• Granger JP, Alexander BT, Llinas MT, et al. Pathophysiology of preeclampsia: linking placental ischemia/hypoxia with microvascular dysfunction. Microcirculation. 2002;9(3):147–160.
   PubMed Web of Science ®Google Scholar
• Egbor M, Ansari T, Morris N, et al. Morphometric placental villous and vascular abnormalities in early- and late-onset pre-eclampsia with and without fetal growth restriction. BJOG. 2006;113(5):580–589.
   PubMed Web of Science ®Google Scholar
• Gilbert JS, Ryan MJ, LaMarca BB, et al. Pathophysiology of hypertension during preeclampsia: linking placental ischemia with endothelial dysfunction. Am J Physiol Heart Circ Physiol. 2008;294(2):H541–H550.
   PubMed Web of Science ®Google Scholar
• Makris A, Thornton C, Thompson J, et al. Uteroplacental ischemia results in proteinuric hypertension and elevated sFLT-1. Kidney Int. 2007;71(10):977–984.
   PubMed Web of Science ®Google Scholar
• Gilbert JS, Gilbert SA, Arany M, et al. Hypertension produced by placental ischemia in pregnant rats is associated with increased soluble endoglin expression. Hypertension. 2009;53(2):399–403.
   PubMed Web of Science ®Google Scholar
• Lamarca B. The role of immune activation in contributing to vascular dysfunction and the pathophysiology of hypertension during preeclampsia. Minerva Ginecol. 2010;62(2):105–120.
   PubMedGoogle Scholar
• Redman CW, Sargent IL. Immunology of pre-eclampsia. Am J Reprod Immunol. 2010;63(6):534–543.
   PubMed Web of Science ®Google Scholar
• Silasi M, Cohen B, Karumanchi SA, et al. Abnormal placentation, angiogenic factors, and the pathogenesis of preeclampsia. Obstet Gynecol Clin North Am. 2010;37(2):239–253.
   PubMed Web of Science ®Google Scholar
• Brosens I, Pijnenborg R, Vercruysse L, et al. The “Great Obstetrical Syndromes” are associated with disorders of deep placentation. Am J Obstet Gynecol. 2011;204(3):193–201.
   PubMed Web of Science ®Google Scholar
• Kwiatkowski S, Dołegowska B, Kwiatkowska E, et al. Maternal endothelial damage as a disorder shared by early preeclampsia, late preeclampsia and intrauterine growth restriction. J Perinat Med. 2017;45(7):793–802.
   PubMed Web of Science ®Google Scholar
• Brosens I, Brosens JJ, Muter J, et al. Preeclampsia: the role of persistent endothelial cells in uteroplacental arteries. Am J Obstet Gynecol. 2019;221(3):219–226.
   PubMed Web of Science ®Google Scholar
• Brosens I, Robertson WB, Dixon HG. The physiological response of the vessels of the placental bed to normal pregnancy. J Pathol Bacteriol. 1967;93(2):569–579.
   PubMedGoogle Scholar
• Brosens I, Puttemans P, Benagiano G. Placental bed research: I. the placental bed: from spiral arteries remodeling to the great obstetrical syndromes. Am J Obstet Gynecol. 2019;221(5):437–456.
   PubMed Web of Science ®Google Scholar
• Harris LK, Benagiano M, D’Elios MM, et al. Placental bed research: II. Functional and immunological investigations of the placental bed. Am J Obstet Gynecol. 2019;221(5):457–469.
   PubMed Web of Science ®Google Scholar
• Gerretsen G, Huisjes HJ, Hardonk MJ, et al. Trophoblast alterations in the placental bed in relation to physiological changes in spiral arteries. BJOG. 1983;90(1):34–39.
   Google Scholar
• Buemi M, Allegra A, D'Anna R, et al. Is apoptosis cause of pre-eclampsia? Eur Rev Med Pharmacol Sci. 1998;2(5–6):185–188.
   PubMedGoogle Scholar
• Huppertz B, Frank HG, Kingdom JC, et al. Villous cytotrophoblast regulation of the syncytial apoptotic cascade in the human placenta. Histochemistry. 1998;110(5):495–508.
   PubMedGoogle Scholar
• DiFederico E, Genbacev O, Fisher SJ. Preeclampsia is associated with widespread apoptosis of placental cytotrophoblasts within the uterine wall. Am J Pathol. 1999;155(1):293–301.
   PubMed Web of Science ®Google Scholar
• Genbacev O, DiFederico E, McMaster M, et al. Invasive cytotrophoblast apoptosis in pre-eclampsia. Hum Reprod. 1999;14(Suppl. 2):59–66.
   PubMedGoogle Scholar
• Huppertz B, Frank HG, Reister F, et al. Apoptosis cascade progresses during turnover of human trophoblast: analysis of villous cytotrophoblast and syncytial fragments in vitro. Lab Invest. 1999;79(12):1687–1702.
   PubMed Web of Science ®Google Scholar
• von Dadelszen P, Watson RW, Noorwali F, et al. Maternal neutrophil apoptosis in normal pregnancy, preeclampsia, and normotensive intrauterine growth restriction. Am J Obstet Gynecol. 1999;181(2):408–414.
   PubMed Web of Science ®Google Scholar
• Darmochwal-Kolarz D, Rolinski J, Leszczynska-Gorzelak B, et al. Fas antigen expression on the decidual lymphocytes of pre-eclamptic patients. Am J Reprod Immunol. 2000;43(4):197–201.
   PubMed Web of Science ®Google Scholar
• Darmochwal-Kolarz D, Leszczynska-Gorzelak B, Rolinski J, et al. The expression and concentrations of Fas/APO-1 (CD95) antigen in patients with severe pre-eclampsia. J Reprod Immunol. 2001;49(2):153–164.
   PubMed Web of Science ®Google Scholar
• Leung DN, Smith SC, To KF, et al. Increased placental apoptosis in pregnancies complicated by preeclampsia. Am J Obstet Gynecol. 2001;184(6):1249–1250.
   PubMed Web of Science ®Google Scholar
• Ishihara N, Matsuo H, Murakoshi H, et al. Increased apoptosis in the syncytiotrophoblast in human term placentas complicated by either preeclampsia or intrauterine growth retardation. Am J Obstet Gynecol. 2002;186(1):158–166.
   PubMed Web of Science ®Google Scholar
• Kadyrov M, Kingdom JC, Huppertz B. Divergent trophoblast invasion and apoptosis in placental bed spiral arteries from pregnancies complicated by maternal anemia and early-onset preeclampsia/intrauterine growth restriction. Am J Obstet Gynecol. 2006;194(2):557–563.
   PubMed Web of Science ®Google Scholar
• Eide IP, Isaksen CV, Salvesen KA, et al. Fetal growth restriction is associated with reduced FASL expression by decidual cells. J Reprod Immunol. 2007;74(1–2):7–14.
   PubMed Web of Science ®Google Scholar
• Elmore S. Apoptosis: a review of programmed cell death. Toxicol Pathol. 2007;35(4):495–516.
   PubMed Web of Science ®Google Scholar
• Nagata S. Fas and Fas ligand: a death factor and its receptor. Adv Immunol. 1994;57:129–144.
   PubMed Web of Science ®Google Scholar
• Nagata S. Apoptosis by death factor. Cell. 1997;88(3):355–365.
   PubMed Web of Science ®Google Scholar
• Israels LG, Israels ED. Apoptosis. Stem Cells. 1999;17(5):306–313.
   PubMed Web of Science ®Google Scholar
• Allaire AD, Ballenger KA, Wells SR. Placental apoptosis in preeclampsia. Obstet Gynecol. 2000;96(2):271–276.
   PubMed Web of Science ®Google Scholar
• Cheng J, Zhou T, Liu C, et al. Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule. Science. 1994;263(5154):1759–1762.
   PubMed Web of Science ®Google Scholar
• Hsu CD, Harirah H, Basherra H, et al. Serum soluble Fas levels in preeclampsia. Obstet Gynecol. 2001;97(4):530–532.
   PubMed Web of Science ®Google Scholar
• Ho L, van Dijk M, Chye STJ, et al. ELABELA deficiency promotes preeclampsia and cardiovascular malformations in mice. Science. 2017;357(6352):707–713.
   PubMed Web of Science ®Google Scholar
• Chng SC, Ho L, Tian J, et al. ELABELA: a hormone essential for heart development signals via the apelin receptor. Dev Cell. 2013;27(6):672–680.
   PubMed Web of Science ®Google Scholar
• Pauli A, Norris ML, Valen E, et al. Toddler: an embryonic signal that promotes cell movement via apelin receptors. Science. 2014;343(6172):1248636–1248636. DOI:https://doi.org/10.7554/eLife.06726
   PubMed Web of Science ®Google Scholar
• Helker CS, Schuermann A, Pollmann C, et al. The hormonal peptide Elabela guides angioblasts to the midline during vasculogenesis. eLife. 2015;4.
   PubMed Web of Science ®Google Scholar
• Hassan SS, Gomez-Lopez N. Reducing maternal mortality: can Elabela help in this fight? Lancet. 2019;394(10192):8–9.
   PubMed Web of Science ®Google Scholar
• Panaitescu B, Romero R, Gomez-Lopez N, et al. ELABELA plasma concentrations are increased in women with late-onset preeclampsia. J Matern Fetal Neonatal Med. 2020;33(1):5–15.
   PubMed Web of Science ®Google Scholar
• Soto E, Romero R, Kusanovic JP, et al. Late-onset preeclampsia is associated with an imbalance of angiogenic and anti-angiogenic factors in patients with and without placental lesions consistent with maternal underperfusion. J Matern Fetal Neonatal Med. 2012;25(5):498–507.
   PubMed Web of Science ®Google Scholar
• Erez O, Romero R, Maymon E, et al. The prediction of late-onset preeclampsia: results from a longitudinal proteomics study. PLOS One. 2017;12(7):e0181468.
   PubMed Web of Science ®Google Scholar
• Romero R, Kim YM, Pacora P, et al. The frequency and type of placental histologic lesions in term pregnancies with normal outcome. J Perinat Med. 2018;46(6):613–630.
   PubMed Web of Science ®Google Scholar
• Kim CJ, Romero R, Chaemsaithong P, et al. Acute chorioamnionitis and funisitis: definition, pathologic features, and clinical significance. Am J Obstet Gynecol. 2015;213(4):S29–S52.
   PubMed Web of Science ®Google Scholar
• Redline RW. Classification of placental lesions. Am J Obstet Gynecol. 2015;213(4):S21–S28.
   PubMed Web of Science ®Google Scholar
• Yoon BH, Romero R, Park JS, et al. The relationship among inflammatory lesions of the umbilical cord (funisitis), umbilical cord plasma interleukin 6 concentration, amniotic fluid infection, and neonatal sepsis. Am J Obstet Gynecol. 2000;183(5):1124–1129.
   PubMed Web of Science ®Google Scholar
• Pacora P, Chaiworapongsa T, Maymon E, et al. Funisitis and chorionic vasculitis: the histological counterpart of the fetal inflammatory response syndrome. J Matern Fetal Neonatal Med. 2002;11(1):18–25.
   PubMedGoogle Scholar
• Lee J, Romero R, Kim SM, et al. A new anti-microbial combination prolongs the latency period, reduces acute histologic chorioamnionitis as well as funisitis, and improves neonatal outcomes in preterm PROM. J Matern Fetal Neonatal Med. 2016;29(5):707–720.
   PubMed Web of Science ®Google Scholar
• Redline RW, Heller D, Keating S, et al. Placental diagnostic criteria and clinical correlation – a workshop report. Placenta. 2005;26(Suppl. A):S114–S117.
   PubMed Web of Science ®Google Scholar
• Khong TY, Mooney EE, Ariel I, et al. Sampling and definitions of placental lesions: Amsterdam Placental Workshop Group Consensus Statement. Arch Pathol Lab Med. 2016;140(7):698–713.
   PubMed Web of Science ®Google Scholar
• Chun D, Braga C, Chow C, et al. Clinical observations on some aspects of hydatidiform moles. BJOG. 1964;71(2):180–184.
   Google Scholar
• Burton GJ, Redman CW, Roberts JM, et al. Pre-eclampsia: pathophysiology and clinical implications. BMJ. 2019;15:366.
   Google Scholar
• Robertson WB, Brosens I, Dixon HG. The pathological response of the vessels of the placental bed to hypertensive pregnancy. J Pathol Bacteriol. 1967;93(2):581–592.
   PubMedGoogle Scholar
• Craven CM, Morgan T, Ward K. Decidual spiral artery remodelling begins before cellular interaction with cytotrophoblasts. Placenta. 1998;19(4):241–252.
   PubMed Web of Science ®Google Scholar
• Neale D, Demasio K, Illuzi J, et al. Maternal serum of women with pre-eclampsia reduces trophoblast cell viability: evidence for an increased sensitivity to Fas-mediated apoptosis. J Matern Fetal Neonatal Med. 2003;13(1):39–44.
   PubMedGoogle Scholar
• Aschkenazi S, Straszewski S, Verwer KM, et al. Differential regulation and function of the Fas/Fas ligand system in human trophoblast cells. Biol Reprod. 2002;66(6):1853–1861.
   PubMed Web of Science ®Google Scholar
• Pritchard N, Kaitu'u-Lino TJ, Gong S, et al. ELABELA/APELA levels are not decreased in the maternal circulation or placenta among women with preeclampsia. Am J Pathol. 2018;188(8):1749–1753.
   PubMed Web of Science ®Google Scholar
• Zhou Q, Zhang K, Guo Y, et al. Elabela-APJ axis contributes to embryonic development and prevents pre-eclampsia in pregnancy. Acta Biochim Biophys Sin (Shanghai). 2018;50(3):319–321.
   PubMed Web of Science ®Google Scholar
• Canfield J, Arlier S, Mong EF, et al. Decreased LIN28B in preeclampsia impairs human trophoblast differentiation and migration. FASEB J. 2019;33(2):2759–2769.
   PubMed Web of Science ®Google Scholar
• Eberlé D, Marousez L, Hanssens S, et al. Elabela and apelin actions in healthy and pathological pregnancies. Cytokine Growth Factor Rev. 2019;46:45–53.
   PubMed Web of Science ®Google Scholar
• Georgiadou D, Afink GB, van Dijk M. The apelinergic-axis in human preeclamptic pregnancies: a systematic review. Preg Hypertens. 2019;17:148–157.
   Web of Science ®Google Scholar
• Huang R, Zhu J, Zhang L, et al. Is ELABELA a reliable biomarker for hypertensive disorders of pregnancy? Preg Hypertens. 2019;17:226–232.
   Web of Science ®Google Scholar
• Liu Y, Wang L, Shi H. The biological function of ELABELA and APJ signaling in the cardiovascular system and pre-eclampsia. Hypertens Res. 2019;42(7):928–934.
   PubMed Web of Science ®Google Scholar
• Zhou L, Sun H, Cheng R, et al. ELABELA, as a potential diagnostic biomarker of preeclampsia, regulates abnormally shallow placentation via APJ. Am J Physiol Endocrinol Metab. 2019;316(5):E773–E781.
   PubMed Web of Science ®Google Scholar
• Xie F, Lv D, Chen L. ELABELA: a novel hormone in cardiac development acting as a new endogenous ligand for the APJ receptor. Acta Biochim Biophys Sin (Shanghai). 2014;46(7):620–622.
   PubMed Web of Science ®Google Scholar
• Wang Z, Yu D, Wang M, et al. Elabela-apelin receptor signaling pathway is functional in mammalian systems. Sci Rep. 2015;5(1):8170.
   PubMed Web of Science ®Google Scholar
• Murza A, Sainsily X, Coquerel D, et al. Discovery and structure–activity relationship of a bioactive fragment of ELABELA that modulates vascular and cardiac functions. J Med Chem. 2016;59(7):2962–2972.
   PubMed Web of Science ®Google Scholar
• Sato T, Sato C, Kadowaki A, et al. ELABELA-APJ axis protects from pressure overload heart failure and angiotensin II-induced cardiac damage. Cardiovasc Res. 2017;113(7):760–769.
   PubMed Web of Science ®Google Scholar
• Yang P, Read C, Kuc RE, et al. Elabela/Toddler is an endogenous agonist of the apelin APJ receptor in the adult cardiovascular system, and exogenous administration of the peptide compensates for the downregulation of its expression in pulmonary arterial hypertension. Circulation. 2017;135(12):1160–1173.
   PubMed Web of Science ®Google Scholar
• Chen H, Wang L, Wang W, et al. ELABELA and an ELABELA fragment protect against AKI. J Am Soc Nephrol. 2017;28(9):2694–2707.
   PubMed Web of Science ®Google Scholar
• Schreiber CA, Holditch SJ, Generous A, et al. Sustained ELABELA gene therapy in high-salt diet-induced hypertensive rats. Curr Gene Ther. 2017;16(5):349–360.
   PubMed Web of Science ®Google Scholar
• Villie P, Lefevre G, Arrestier R, et al. Research letter: Elabela concentration is not decreased in maternal plasma before the onset of preeclampsia. Am J Obstet Gynecol. 2018;220(3):284–285.
   PubMed Web of Science ®Google Scholar
• Yang X, Bian Y, Wan J, et al. Variants in the 5′-UTR of APELA gene in women with preeclampsia. Prenat Diagn. 2019;39(4):308–313.
   PubMed Web of Science ®Google Scholar
• Georgiadou D, Boussata S, van Dijk M. ELABELA measurements by commercial ELISA kits require sample extraction. Am J Physiol Endocrinol Metab. 2019;317(6):E1218–E1219.
   PubMed Web of Science ®Google Scholar
• Etzioni R, Kooperberg C, Pepe M, et al. Combining biomarkers to detect disease with application to prostate cancer. Biostatistics. 2003;4(4):523–538.
   PubMed Web of Science ®Google Scholar
• Bast RC Jr, Lilja H, Urban N, et al. Translational crossroads for biomarkers. Clin Cancer Res. 2005;11(17):6103–6108.
   PubMed Web of Science ®Google Scholar
• Nicolaides KH. Turning the pyramid of prenatal care. Fetal Diagn Ther. 2011;29(3):183–196.
   PubMed Web of Science ®Google Scholar
• Poon LC, Nicolaides KH. First-trimester maternal factors and biomarker screening for preeclampsia. Prenat Diagn. 2014;34(7):618–627.
   PubMed Web of Science ®Google Scholar
• Bahado-Singh RO, Syngelaki A, Akolekar R, et al. Validation of metabolomic models for prediction of early-onset preeclampsia. Am J Obstet Gynecol. 2015;213(4):530–530.e10.
   PubMed Web of Science ®Google Scholar
• Wang X, Gao H. Prevention of preeclampsia in high-risk patients with low-molecular-weight heparin: a meta-analysis. J Matern Fetal Neonatal Med. 2018:1–7. DOI:https://doi.org/10.1080/14767058.2018.1543656
   Google Scholar
• Chaiworapongsa T, Chaemsaithong P, Yeo L, et al. Pre-eclampsia part 1: current understanding of its pathophysiology. Nat Rev Nephrol. 2014;10(8):466–480.
   PubMed Web of Science ®Google Scholar
• Sibai BM, Gordon T, Thom E, et al. Risk factors for preeclampsia in healthy nulliparous women: a prospective multicenter study. The National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. Am J Obstet Gynecol. 1995;172(2):642–648.
   PubMed Web of Science ®Google Scholar
• Sibai BM, Ewell M, Levine RJ, et al. Risk factors associated with preeclampsia in healthy nulliparous women. The calcium for preeclampsia Prevention (CPEP) Study Group. Am J Obstet Gynecol. 1997;177(5):1003–1010.
   PubMed Web of Science ®Google Scholar
• Poon LC, Kametas NA, Chelemen T, et al. Maternal risk factors for hypertensive disorders in pregnancy: a multivariate approach. J Hum Hypertens. 2010;24(2):104–110.
   PubMed Web of Science ®Google Scholar
• Wright D, Syngelaki A, Akolekar R, et al. Competing risks model in screening for preeclampsia by maternal characteristics and medical history. Am J Obstet Gynecol. 2015;213(1):62–62.e10.
   PubMed Web of Science ®Google Scholar
• Košir Pogacnik R, Trojner Bregar A, Lucovnik M, et al. The effect of interaction between parity, gestational diabetes, and pregravid obesity on the incidence of preeclampsia. J Matern Fetal Neonatal Med. 2018;33:1–4.
   PubMed Web of Science ®Google Scholar
• Premru-Srsen T, Kocic Z, Fabjan Vodusek V, et al. Total gestational weight gain and the risk of preeclampsia by pre-pregnancy body mass index categories: a population-based cohort study from 2013 to 2017. J Perinat Med. 2019;47(6):585–591.
   PubMed Web of Science ®Google Scholar
• Crispi F, Domínguez C, Llurba E, et al. Placental angiogenic growth factors and uterine artery Doppler findings for characterization of different subsets in preeclampsia and in isolated intrauterine growth restriction. Am J Obstet Gynecol. 2006;195(1):201–207.
   PubMed Web of Science ®Google Scholar
• Crispi F, Llurba E, Domínguez C, et al. Predictive value of angiogenic factors and uterine artery Doppler for early- versus late-onset pre-eclampsia and intrauterine growth restriction. Ultrasound Obstet Gynecol. 2008;31(3):303–309.
   PubMed Web of Science ®Google Scholar
• Llurba E, Carreras E, Gratacós E, et al. Maternal history and uterine artery Doppler in the assessment of risk for development of early- and late-onset preeclampsia and intrauterine growth restriction. Obstet Gynecol Int. 2009;2009:1–6.
   Google Scholar
• Wright D, Tan MY, O’Gorman N, et al. Predictive performance of the competing risk model in screening for preeclampsia. Am J Obstet Gynecol. 2019;220(2):199–199.e13.
   PubMed Web of Science ®Google Scholar
• Audibert F, Boucoiran I, An N, et al. Screening for preeclampsia using first-trimester serum markers and uterine artery Doppler in nulliparous women. Am J Obstet Gynecol. 2010;203(4):383.e1–383.e8.
   Web of Science ®Google Scholar
• Kuc S, Wortelboer EJ, van Rijn BB, et al. Evaluation of 7 serum biomarkers and uterine artery Doppler ultrasound for first-trimester prediction of preeclampsia: a systematic review. Obstet Gynecol Surv. 2011;66(4):225–239.
   PubMed Web of Science ®Google Scholar
• Tobinaga CM, Torloni MR, Gueuvoghlanian-Silva BY, et al. Angiogenic factors and uterine Doppler velocimetry in early- and late-onset preeclampsia. Acta Obstet Gynecol Scand. 2014;93(5):469–476.
   PubMed Web of Science ®Google Scholar
• Seravalli V, Grimpel YI, Meiri H, et al. Relationship between first-trimester serum placental protein-13 and maternal characteristics, placental Doppler studies and pregnancy outcome. J Perinat Med. 2016;44(5):543–549.
   PubMed Web of Science ®Google Scholar
• Chuah TT, Tey WS, Ng MJ, et al. Serum sFlt-1/PlGF ratio has better diagnostic ability in early- compared to late-onset pre-eclampsia. J Perinat Med. 2018;47(1):35–40.
   PubMed Web of Science ®Google Scholar
• Cift T, Begum AMA, Cetin B, et al. Serum caveolin-1 levels in patients with preeclampsia. J Matern Fetal Neonatal Med. 2018;35:1–6.
   Google Scholar
• Monteith C, Egan K, O’Connor H, et al. Early onset preeclampsia is associated with an elevated mean platelet volume (MPV) and a greater rise in MPV from time of booking compared with pregnant controls: results of the CAPE study. J Perinat Med. 2018;46(9):1010–1015.
   PubMed Web of Science ®Google Scholar
• Romero R, Chaemsaithong P, Tarca AL, et al. Maternal plasma-soluble ST2 concentrations are elevated prior to the development of early and late onset preeclampsia – a longitudinal study. J Matern Fetal Neonatal Med. 2018;31(4):418–432.
   PubMed Web of Science ®Google Scholar
• Bednarek-Jędrzejek M, Kwiatkowski S, Ksel-Hryciów J, et al. The sFlt-1/PlGF ratio values within the <38, 38–85 and >85 brackets as compared to perinatal outcomes. J Perinat Med. 2019;47(7):732–740.
   PubMed Web of Science ®Google Scholar
• Mayer-Pickel K, Stern C, Eberhard K, et al. Comparison of mean platelet volume (MPV) and sFlt-1/PlGF ratio as predictive markers for preeclampsia. J Matern Fetal Neonatal Med. 2019;1–8. DOI:https://doi.org/10.1080/14767058.2019.1638356
   Google Scholar
• Tarca AL, Romero R, Benshalom-Tirosh N, et al. The prediction of early preeclampsia: results from a longitudinal proteomics study. PLOS One. 2019;14(6):e0217273.
   PubMed Web of Science ®Google Scholar
• Yuan Y, Tai W, Xu P, et al. Association of maternal serum 25-hydroxyvitamin D concentrations with risk of preeclampsia: a nested case-control study and meta-analysis. J Matern Fetal Neonatal Med. 2019;1–10. DOI:https://doi.org/10.1080/14767058.2019.1640675
   Google Scholar
• Zhao X, Frempong ST, Duan T. Uric acid levels in gestational hypertensive women predict preeclampsia and outcome of small-for-gestational-age infants. J Matern Fetal Neonatal Med. 2019;1–7. DOI:https://doi.org/10.1080/14767058.2019.1671339
   Google Scholar
• Griffin M, Shennan AH. Clinical applications of biomarkers in preeclampsia. Biomarkers Med. 2014;8(4):459–470.
   PubMed Web of Science ®Google Scholar
• Wu P, van den Berg C, Alfirevic Z, et al. Early pregnancy biomarkers in pre-eclampsia: a systematic review and meta-analysis. Int J Mol Sci. 2015;16(9):23035–23056.
   PubMed Web of Science ®Google Scholar